Portfolio company
ProFound Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops protein therapeutics and drug targets for pharmaceutical partners by identifying previously undiscovered proteins within the human genome using computational models.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Profluent
This company develops generative artificial intelligence models to design novel proteins and gene editors for pharmaceutical, biotechnology and agricultural organisations.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
DreamFold
This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.
CHARM Therapeutics
This company develops small-molecule drugs for cancer patients using a deep-learning platform that models protein-ligand interactions to identify novel therapeutic targets.
ProtOS
This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.
Profluent Bio
Profluent Bio develops generative artificial intelligence models to design novel functional proteins for biopharmaceutical companies and industrial partners.
Deep Origin
This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.
